Home/Filings/4/0001209191-23-027505
4//SEC Filing

GREGORY JULIA P 4

Accession 0001209191-23-027505

CIK 0001549595other

Filed

May 3, 8:00 PM ET

Accepted

May 4, 7:55 PM ET

Size

9.3 KB

Accession

0001209191-23-027505

Insider Transaction Report

Form 4
Period: 2023-05-04
Transactions
  • Award

    Director Stock Option (right to buy)

    2023-05-04+25,00025,000 total
    Exercise: $9.44Exp: 2033-05-03Common Stock (25,000 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 4, 2024, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date.

Issuer

Nurix Therapeutics, Inc.

CIK 0001549595

Entity typeother

Related Parties

1
  • filerCIK 0001226675

Filing Metadata

Form type
4
Filed
May 3, 8:00 PM ET
Accepted
May 4, 7:55 PM ET
Size
9.3 KB